Cipla sees no major impact on biz from Donald Trump admin’s decision to pause foreign aid: Umang Vohra
Mumbai: Drugmaker Cipla, which participates in tenders for a US-supported global programme to supply HIV medications, doesn’t see any major impact from the Donald Trump administration’s decision to pause foreign aid, including the President’s Emergency Plan for AIDS Relief (PEPFAR), a top executive of the company said.
Source : Economictimes